scispace - formally typeset
Journal ArticleDOI

Nanostructured lipid (NLCs) carriers as a bioavailability enhancement tool for oral administration.

TLDR
It was concluded that the N LCs enhances the oral bioavailability of the drug and may decrease the side effects and toxicity of the lipids used in other polymeric NPs as NLCs uses physiological and biodegradable lipids.
Abstract
Context: Nanostructured lipid carrier (NLCs) is the second generation solid lipid nanoparticles (NPs) made up of physiological, biocompatible, biodegradable, non-sensitizing and non-irritating lipids.Objective: The main objective of this review is to explore the role of NLCs system for delivering drugs by oral route and thus increasing the oral bioavailability.Methods: The present review article highlights the definition and types of NLCs and their importance as colloidal carriers including the production techniques and their formulation. This review article also deals with the fate of lipids used in the NLCs formulation and the NLCs toxicity.Conclusion: On the basis of the literature survey done, it was concluded that the NLCs enhances the oral bioavailability of the drug and may decrease the side effects and toxicity of the lipids used in other polymeric NPs as NLCs uses physiological and biodegradable lipids.

read more

Citations
More filters
Journal ArticleDOI

Nanostructured lipid carriers: Promising drug delivery systems for future clinics.

TL;DR: The understanding of the nanostructured lipid carriers (NLC)-based formulations has improved with continuing research recently, and the result has seen an increase in the use of these in the clinical setting.
Journal ArticleDOI

Nanostructured lipid carriers for site-specific drug delivery

TL;DR: This review highlights the NLC with focus on the structure, the various fabrication techniques used and the characterization techniques which are critical in the development of a suitable and stable formulation.
Journal ArticleDOI

Lipid nanoparticles: Different preparation techniques, characterization, hurdles, and strategies for the production of solid lipid nanoparticles and nanostructured lipid carriers for oral drug delivery

TL;DR: This review highlights the simple and easily scaled-up novel SLN and NLC along with their different production techniques, hurdles, and strategies for the production of LNs, characterization, lyophilization and drug release and summarizes the research findings reported by the different researchers regarding the different method of preparation, excipients and their significant findings.
Journal ArticleDOI

Nanocarrier-based systems for targeted and site specific therapeutic delivery.

TL;DR: The present review describes major advantages and limitations of organic and inorganic nanocarriers or living cell-based drug and nucleic acid delivery systems.
Journal ArticleDOI

Nanostructured lipid carrier system for topical delivery of terbinafine hydrochloride

TL;DR: The pharmacodynamic studies indicated that TH-NLC gel efficiently reduced the fungal burden in shorter duration of time as compared to marketed formulation, and could be a potential alternative for treatment of topical fungal infection after clinical evaluation in near future.
References
More filters
Journal ArticleDOI

Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art.

TL;DR: Relevant issues for the introduction of SLN to the pharmaceutical market, such as status of excipients, toxicity/tolerability aspects and sterilization and long-term stability including industrial large scale production are discussed.
Journal ArticleDOI

Solid lipid nanoparticles: Production, characterization and applications

TL;DR: An overview about the selection of the ingredients, different ways of SLN production and SLN applications, and the in vivo fate of the carrier are presented.
Journal ArticleDOI

Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations.

TL;DR: As a novel type of lipid nanoparticles with solid matrix, the nanostructured lipid carriers (NLC) are presented and improvements discussed, for example, increase in loading capacity, physical and chemical long-term stability, triggered release and potentially supersaturated topical formulations.
Journal ArticleDOI

Solid lipid nanoparticles for parenteral drug delivery.

TL;DR: The biological activity of parenterally applied SLN and biopharmaceutical aspects such as pharmacokinetic profiles as well as toxicity aspects are reviewed.
Journal ArticleDOI

Nanostructured lipid matrices for improved microencapsulation of drugs

TL;DR: A special preparation process-applicable to NLC but also SLN-allows the production of highly concentrated particle dispersions (>30-95%).
Related Papers (5)